Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amyris Stock Jumped Today


Shares of Amyris (NASDAQ: AMRS) were jumping 14.8% as of 3:43 p.m. EDT on Friday. The big gain came after the synthetic biology company announced encouraging in vivo (in the body) results from a study evaluating an intranasal RNA COVID-19 vaccine Amyris is developing with the Infectious Disease Research Institute.

Amyris said the results from the study found that its intranasal vaccine generates antibodies against SARS-CoV-2 and provides protection from upper respiratory infection by the virus. The company thinks the experimental vaccine could provide more protection against coronavirus variants than current messenger RNA vaccines do.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments